D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.41% |
| 2 | Technology | 9.4% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Caleres
CAL
$420M
| $1.08M | ﹤0.01% |
+34,137
| New | +$1.07M |
|
|
ONCE
2627
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.08M | ﹤0.01% |
+17,993
| New | +$1.19M |
|
|
BV
2628
DELISTED
Bazaarvoice, Inc.
BV
| $1.08M | ﹤0.01% |
184,065
-12,437
| -6% | -$72.3K |
|
|
PSEM
2629
DELISTED
PERICOM SEMICONDUCTOR CP
PSEM
| $1.08M | ﹤0.01% |
82,367
+29,892
| +57% | +$405K |
|
|
FCB
2630
DELISTED
FCB Financial Holdings, Inc.
FCB
| $1.08M | ﹤0.01% |
34,008
-9,614
| -22% | -$275K |
|
|
KITE
2631
DELISTED
Kite Pharma, Inc.
KITE
| $1.08M | ﹤0.01% |
17,700
+5,300
| +43% | +$302K |
|
2632
Hormel Foods
HRL
$14.3B
| $1.08M | ﹤0.01% |
+38,238
| New | +$1.08M |
|
|
BRKL
2633
DELISTED
Brookline Bancorp
BRKL
| $1.07M | ﹤0.01% |
95,107
+54,450
| +134% | +$593K |
|
2634
Mizuho Financial
MFG
$129B
| $1.07M | ﹤0.01% |
247,056
-75,167
| -23% | -$302K |
|
|
STBZ
2635
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.07M | ﹤0.01% |
49,277
-17,727
| -26% | -$365K |
|
2636
Nu Skin
NUS
$250M
| $1.06M | ﹤0.01% |
+22,509
| New | +$1.22M |
|
2637
Revvity
RVTY
$12.1B
| $1.06M | ﹤0.01% |
20,158
-21,736
| -52% | -$1.13M |
|
|
NGHC
2638
DELISTED
National General Holdings Corp
NGHC
| $1.06M | ﹤0.01% |
50,881
+37,180
| +271% | +$729K |
|
|
ALDR
2639
PUT
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.06M | ﹤0.01% |
+20,000
| New | +$727K |
|
|
GSIG
2640
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $1.06M | ﹤0.01% |
70,439
+542
| +0.8% | +$7.84K |
|
|
TTSH
2641
DELISTED
Tile Shop Holdings
TTSH
| $1.06M | ﹤0.01% |
74,573
-25,092
| -25% | -$338K |
|
|
LMOS
2642
DELISTED
Lumos Networks Corp
LMOS
| $1.06M | ﹤0.01% |
71,508
-7,693
| -10% | -$114K |
|
2643
CALL
Pitney Bowes
PBI
$2.46B
| $1.05M | ﹤0.01% |
50,700
| – | – |
|
2644
TSMC
TSM
$2.07T
| $1.05M | ﹤0.01% |
46,415
-512,775
| -92% | -$12.2M |
|
|
NEWP
2645
DELISTED
NEWPORT CORP
NEWP
| $1.05M | ﹤0.01% |
55,419
+12,710
| +30% | +$246K |
|
2646
Silgan Holdings
SLGN
$4.92B
| $1.04M | ﹤0.01% |
39,548
-21,046
| -35% | -$583K |
|
2647
REX American Resources
REX
$1.44B
| $1.04M | ﹤0.01% |
98,166
-97,446
| -50% | -$1.03M |
|
2648
CALL
Tyson Foods
TSN
$21.4B
| $1.04M | ﹤0.01% |
24,400
| – | – |
|
|
SFXE
2649
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $1.04M | ﹤0.01% |
231,521
+218,573
| +1,688% | +$979K |
|
|
NEWS
2650
DELISTED
NewStar Financial, Inc.
NEWS
| $1.04M | ﹤0.01% |
94,237
-8,311
| -8% | -$92.7K |
|
Similar funds
D.E. Shaw & Co's Q2 2015 Portfolio in Review
As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.
- D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
- D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.